TITLE
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

ORGANISM
Homo sapiens

SUMMARY
To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines.

DESIGN
Total RNA collected from a panel of HNSCC cell lines.

PLATFORM
GPL570 [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

CITATIONS
25081901

